moxisylyte has been researched along with Bradyarrhythmia in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roquebert, J | 1 |
| Demichel, P | 1 |
| Malek, A | 1 |
| Judge, TG | 1 |
1 review available for moxisylyte and Bradyarrhythmia
| Article | Year |
|---|---|
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
1 other study available for moxisylyte and Bradyarrhythmia
| Article | Year |
|---|---|
Effects of thymoxamine and its metabolites on clonidine-induced hypotension and bradycardia in rats.
Topics: Anesthesia; Animals; Blood Pressure; Bradycardia; Clonidine; Heart Rate; Hypotension; Male; Moxisyly | 1982 |